Diabetes stands for a kind of disease, especially diabetes mellitus, characterized by super high levels of glucose (sugar) in the blood. The product categories for this condition’s management fall within glucose monitoring devices (e.g. lancets, blood glucose meters) and insulin administration devices (e.g. insulin pumps, pens and syringes).
Globally, the Diabetes Care Market trends toward approaching far over EUR 19 billion by end-2018. The market will primarily be jet-propelled by the universal upsurge in the diabetes-stricken population, and the fast adoption tempos of less or non-invasive breakthroughs, including, among others, the EyeSense's blood glucose monitoring (BGM) devices, NBM-200G, 8 MediSensors' optical glucose monitoring technologies, Easy Check’s breath-based glucose testers. The dominating vendors in this marketplace include Roche, LifeScan, Sanofi, Novo Nordisk, Bayer Diabetes, and Lilly.
The research reports within the confines of this Catalogue analyze the Diabetes Care Market’s performance in a worldwide scenario, as well as across different geographies. The researches extensively review major market trends, driving forces and restraints for giving a clearer idea of the market structure. Additionally, the reports give unbiased insights into the competitive environment, major producers of anti-diabetic medications and diabetes devices, key products marketed and those currently in development. The global Diabetes Care Market forecasts are also available in the research reports.
Publications found:
46
Sort by:
